Dan Roark is a CEO at Gestalt Diagnostics, LLC based in Spokane, Washington, United States, North America. Mr. Roark is an experienced CEO, serial entrepreneur, active angel investor and board member for technology businesses with experience in the life science industry and beyond. He is currently the CEO of Gestalt Diagnostics. His focus has encompassed development and commercialization of innovative and patented industrial automation and consumables that have fueled several technologies including the Human Genome Project, High Throughput Drug Screening at top tier pharmaceutical and biotech companies, improved food crop breeding operations at leading Agriculture companies, diagnostics biomarker testing for cancer and genetic disorders, blood bank screening for infectious diseases, and provided automated storage systems holding millions of chemical or biological samples used for drug development and population genomics efforts for world leading pharmaceutical and government sponsored academic institutes and clinical hospitals. His leadership spans engineering, business operations, and market development efforts globally. He received B.S. degrees in Biochemistry and Chemical Engineering from Whitworth University in 1984 and Washington State University in 1987, where he was awarded Distinguished Alumnus 2017 for the Voiland School of Chemical Engineering and Bioengineering. He is affiliated with the Spokane Angel Alliance and KickStart investment funds.
Current Position: CEO
Company: Gestalt Diagnostics, LLC
Location: Spokane, Washington, United States, North America
Social: Professional profiles available
Network: Extensive professional connections